Skip to main content
Caplight Logo









ACES Diagnostics

ACES Diagnostics

Private
Paradise Valley, ArizonaHealthcare & Life Scienceshttps://www.acesdiagnostics.com/

Last Round

Seed Round

Jun 25, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

ACES Diagnostics, Inc. is a healthtech company that develops diagnostic testing technologies for the early detection of infectious diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

Lyme disease diagnosticsLyme testAI diagnosticsearly Lyme detectionin vitro diagnosticsIVDmachine learning diagnosticstick-borne illness diagnosticsmultiplexed immunoassaydiagnostic biomarkersdiagnostic algorithmmedtechbiotechnologyprecision medicineLuminex immunoassay

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ACES Diagnostics Comparables

Compare ACES Diagnostics with similar companies based on industry and business-model similarity.

ACES Diagnostics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BlueArc Biosciences
87%
Vibrant Sciences LLC
79%
IGeneX
78%

ACES Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJun 25, 2026

Key People

Founding team and executive leadership

Tammy Crawford

Chief Executive Officer

Executive Team

Glenn de Souza

Chief Operating Officer

Executive Team

ACES Diagnostics Investors

Notable investors and investment history

ACES Diagnostics investors
InvestorRounds
Bay Area Lyme FoundationSeed Round
AZAdvancesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 25, 2026

    $400K raised in Seed Round.

  • Dec 23, 2025

    Grew 75% QoQ from 4 to 7 employees.

ACES Diagnostics Filings

Explore SEC and related filing metadata, where available.

ACES Diagnostics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ACES Diagnostics's valuation, stock price, and market status.

Is ACES Diagnostics a public or private company?

ACES Diagnostics is a private company.

What is the current stock price of ACES Diagnostics?

ACES Diagnostics is a private company with no public stock price. No recent secondary market data is available.

How much is ACES Diagnostics worth (valuation)?

Valuation information for ACES Diagnostics is not publicly available.

Can I buy ACES Diagnostics stock?

ACES Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ACES Diagnostics's last funding round?

ACES Diagnostics's most recent funding round was Seed Round on June 25, 2026.

Who are the main investors in ACES Diagnostics?

Investor information for ACES Diagnostics is not publicly disclosed.

Will ACES Diagnostics IPO soon?

No public IPO plans have been announced for ACES Diagnostics.

How can I track ACES Diagnostics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ACES Diagnostics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersParadise Valley, Arizona
Employee Range10
Year Founded2017
Last FundingJun 25, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?